No need to login to view prices!
|Create new account|
The BIOKÉ webshop is closed until January 2nd, 2019. We wish you a successful 2019!
LEIDEN, June 7, 2019 - BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), announced that it has signed a distribution agreement with Parallex BioAssays, an innovative biotech company that develops breakthrough antibody microarrays for the biomedical and food industries, to distribute the SnapChipTM Cellular Signaling Series in the Netherlands, Belgium and Luxembourg (collectively, the “BeNeLux”) market.
"The SnapChipTM is a simple microarray-to-microarray approach to eliminate false signals in multiplexed immunoassays, as it reproduces the conditions of a common ELISA by colocalizing the capture and detection antibodies in nanodroplets. This cross-reaction-free platform offers high quality results while permitting rapid, flexible and customized multiplexed immunoassay development that will help accelerate academic and industrial research”, said Sebastien Bergeron, CEO Parallex. “We are excited about our collaboration with BIOKÉ whose highly experienced and dedicated team is successfully serving life science institutes in the BeneLux for the last 15 years"
"Cross-reaction of detection antibodies is a major hindrance to most researchers employing the traditional immunoassays. The SnapChip is a revolutionary microarray solution to this problem that will provide our customers with a highly sensitive, multiparametric, user-friendly technology saving them their precious time and samples”, said Jolanda Scheenhart, Product Specialist Protein & Cellular Analysis BIOKÉ. “The addition of Parallex to the BIOKÉ portfolio not only complements our existing products but also strengthens our ability to provide customers with a complete solution for their research pertaining to protein and cellular analysis.”
Parallex BioAssays was founded in 2015 in Montréal, Canada, with a mission to offer innovative and customizable solutions to accelerate academic and industrial research. Parallex has developed a new microarray format called the SnapChipTM technology, that has made it possible for researchers to eliminate the cross-reaction issues inherent to multiplexed immunoassays. This patented technology provides them with physically isolated micro-assays that can be combined in a single and highly customizable chip without any compromise on the quality of the results. Also, this unique multiparametric Chip platform measures post-translational modifications, protein isoforms and can also include binding partners. It is performed on standard planar arrays, representing an attractive solution for scientists to accelerate their research without investing in expensive equipment. For additional information please visit the Parallex website at www.parallexbio.com.
Founded in 2004, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and high-performance applications and workflows for genomics, protein analysis and cell biology. In July 2009 Cell Signaling Technology, Inc. (CST) - the market leader in the development of high quality antibody products and technologies - acquired BIOKÉ BV and BIOKÉ became a business unit of Cell Signaling Technology Europe (CST EU). CST EU and BIOKÉ hold offices in Leiden, the Netherlands. For additional information please visit the BIOKÉ website at www.bioke.com.
Phone. +31 (0)71 7200 220